Form 8-K - Current report:
SEC Accession No. 0001104659-21-150193
Filing Date
2021-12-16
Accepted
2021-12-16 06:05:15
Documents
14
Period of Report
2021-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135560d1_8k.htm   iXBRL 8-K 39386
2 EXHIBIT 99.1 tm2135560d1_ex99-1.htm EX-99.1 27840
6 GRAPHIC tm2135560d1_ex99-1img001.jpg GRAPHIC 1812
  Complete submission text file 0001104659-21-150193.txt   255849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20211215.xsd EX-101.SCH 3031
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20211215_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20211215_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2135560d1_8k_htm.xml XML 3604
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 211495912
SIC: 2834 Pharmaceutical Preparations